New York state opens antitrust probe of Mylan's EpiPen

September 6, 2016

New York state has launched an antitrust probe into Mylan's sale of the EpiPen anti-allergy injector to local school systems, New York's attorney general announced Tuesday.

A preliminary review by the New York office concluded that Mylan may have inserted anticompetitive terms into EpiPen sales contracts with local school systems, said Attorney General Eric Schneiderman.

"No child's life should be put at risk because a parent, school, or healthcare provider cannot afford a simple, life-saving device because of a drug-maker's anti-competitive practices," Schneiderman said.

The probe comes as Mylan faces criticism from Democratic presidential candidate Hillary Clinton, among others, after instituting a five-fold increase in the price of the life-saving epinephrine injectors over a decade.

A Mylan spokeswoman said the drugmaker's "EpiPen4Schools" program has provided more than 700,000 free auto-injectors to more than 65,000 schools in the US and that the program "continues to adhere to all applicable laws and regulations."

The drugmaker previously offered to sell schools additional injectors beyond those provided for free under the program, but that "such restriction no longer remains," the Mylan spokeswoman said.

Since coming under fire for higher prices last month, Mylan has announced plans to offer a generic version of EpiPen and to expand patient assistance programs.

Democratic Senator Amy Klobuchar, whose daughter relies on EpiPen, has called on the Federal Trade Commission to launch an anti-trust investigation against the company, which has a near-monopoly in the market.

Mylan shares rose 0.8 percent to $40.29 in afternoon trade.

Explore further: Price rise for anti-allergy EpiPen sparks furor

Related Stories

Price rise for anti-allergy EpiPen sparks furor

August 23, 2016
A five-fold price hike for EpiPen, which allergy sufferers use to counteract life-threatening reactions, has made Mylan the newest drugmaker to come under attack in the United States for profiteering.

Top US medical group blasts EpiPen's 'exorbitant' costs

August 24, 2016
The American Medical Association urged the maker of the EpiPen, a life-saving device that counteracts severe allergies, to drop its price Wednesday as public outrage mounted over a soaring cost hike.

Mylan boosts EpiPen patient programs, doesn't budge on price

August 25, 2016
Mylan is bulking up programs that help patients pay for its EpiPen emergency allergy treatment after weathering heated criticism about an average cost that has soared over the past decade.

Mylan launching cheaper, generic version of EpiPen

August 29, 2016
The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues—and looming competition threatens its near-monopoly.

Pediatric allergist discusses EpiPen controversy

August 26, 2016
Members of Congress are calling for an investigation into the EpiPen maker Mylan. The pharmaceutical company has increased the price of EpiPens, from about $100 in 2008 to more than $500 today.

Clinton offers plan to prevent 'excessive' drug price hikes

September 2, 2016
Following the public outcry over steep increases in price for an emergency allergy treatment, Hillary Clinton is pledging to better protect patients from such costs.

Recommended for you

Doctors prescribe opioids at high rates to those at increased overdose risk

April 24, 2018
The number of first-time prescriptions for opioid drugs has not risen since about 2010, according to UCLA researchers. However, patients taking a class of drug known to increase the risk for overdoses were likelier to receive ...

Study: Ibuprofen, acetaminophen more effective than opioids in treating dental pain

April 17, 2018
Opioids are not among the most effective—or longest lasting—options available for relief from acute dental pain, a new examination of the results from more than 460 published studies has found.

Text messaging tool may help fight opioid epidemic

April 17, 2018
A new automated text messaging service may curb opioid abuse and reduce the likelihood of relapse while also decreasing treatment costs, according to researchers at Washington University School of Medicine and Epharmix, a ...

Marijuana-based drug gets positive review from US agency

April 17, 2018
A closely watched medicine made from the marijuana plant reduces seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday.

Post-surgical opioids can, paradoxically, lead to chronic pain

April 16, 2018
Giving opioids to animals to quell pain after surgery prolongs pain for more than three weeks and primes specialized immune cells in the spinal cord to be more reactive to pain, according to a new study by the University ...

Animal study suggests common diabetes drug may also help with nicotine withdrawal

April 5, 2018
In a mouse study, a drug that has helped millions of people around the world manage their diabetes might also help people ready to kick their nicotine habits.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.